Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis
Authors:
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 316 (2) , 139-150
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Deadly Teamwork: Neural Cancer Stem Cells and the Tumor MicroenvironmentCell Stem Cell, 2011
- TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental gliomaCell Death & Differentiation, 2010
- Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeuticsProceedings of the National Academy of Sciences, 2010
- Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastomaBritish Journal of Cancer, 2010
- Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastomaJournal of Neuro-Oncology, 2010
- Challenges in Clinical Design of Immunotherapy Trials for Malignant GliomaNeurosurgery Clinics of North America, 2010
- Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyBritish Journal of Cancer, 2009
- Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiformeBritish Journal of Cancer, 2009
- Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor GrowthStem Cells, 2009
- Therapeutic Targets in Malignant Glioblastoma MicroenvironmentSeminars in Radiation Oncology, 2009